Zytoprotec Appoints Two Board Members
This article was originally published in Scrip
Biotech company Zytoprotec has appointed Joerg Vienken and Norbert Riedel to its supervisory board. From 1996 to 2013, Vienken was vice president biosciences at Fresenius Medical Care and is a member of the scientific board of the Berlin-Brandenburg Center for regenerative therapies, the Institute of Biocybernetics and Biomedical Engineering of the Polish Academy of Sciences. For more than 10 years Riedel was head of research and development at Baxter and has been involved with or held positions at companies including ARIAD, Naurex (acquired by Allergan), Aptinyx, Jazz Pharmaceuticals and MediGene.